Detailed information for compound 1690436

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 265.313 | Formula: C15H15N5
  • H donors: 2 H acceptors: 3 LogP: 1 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: NCCNc1nc(cc2c1cncc2)c1ccncc1
  • InChi: 1S/C15H15N5/c16-4-8-19-15-13-10-18-7-3-12(13)9-14(20-15)11-1-5-17-6-2-11/h1-3,5-7,9-10H,4,8,16H2,(H,19,20)
  • InChiKey: WMHOCZAKJFCHBH-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens protein kinase C, eta Starlite/ChEMBL References
Homo sapiens protein kinase C, beta Starlite/ChEMBL References
Homo sapiens protein kinase C, epsilon Starlite/ChEMBL References
Homo sapiens protein kinase C, delta Starlite/ChEMBL References
Homo sapiens protein kinase C, alpha Starlite/ChEMBL References
Homo sapiens protein kinase C, theta Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus granulosus protein kinase c epsilon type Get druggable targets OG5_129314 All targets in OG5_129314
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132502 All targets in OG5_132502
Schistosoma japonicum IPR000477,RNA-directed DNA polymerase (Reverse transcriptase),domain-containing Get druggable targets OG5_129482 All targets in OG5_129482
Echinococcus multilocularis Protein kinase C, brain isozyme Get druggable targets OG5_129482 All targets in OG5_129482
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132502 All targets in OG5_132502
Echinococcus multilocularis serine threonine protein kinase Get druggable targets OG5_129482 All targets in OG5_129482
Schistosoma mansoni serine/threonine protein kinase Get druggable targets OG5_129482 All targets in OG5_129482
Schistosoma japonicum Protein kinase C alpha type, putative Get druggable targets OG5_129482 All targets in OG5_129482
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_129482 All targets in OG5_129482
Entamoeba histolytica PH domain containing protein kinase, putative Get druggable targets OG5_129314 All targets in OG5_129314
Brugia malayi protein kinase C II. Get druggable targets OG5_129314 All targets in OG5_129314
Schistosoma japonicum Protein kinase C epsilon type, putative Get druggable targets OG5_129314 All targets in OG5_129314
Schistosoma japonicum Calcium-dependent protein kinase C, putative Get druggable targets OG5_129482 All targets in OG5_129482
Schistosoma mansoni serine/threonine protein kinase Get druggable targets OG5_129482 All targets in OG5_129482
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132502 All targets in OG5_132502
Echinococcus granulosus serine:threonine protein kinase N2 Get druggable targets OG5_129314 All targets in OG5_129314
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132502 All targets in OG5_132502
Schistosoma japonicum Protein kinase C gamma type, putative Get druggable targets OG5_129482 All targets in OG5_129482
Echinococcus multilocularis protein kinase c epsilon type Get druggable targets OG5_129314 All targets in OG5_129314
Onchocerca volvulus Get druggable targets OG5_132502 All targets in OG5_132502
Echinococcus granulosus Protein kinase C brain isozyme Get druggable targets OG5_129482 All targets in OG5_129482
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132502 All targets in OG5_132502
Candida albicans protein kinase C similar to S. cerevisiae PKC1 (YBL105C) Get druggable targets OG5_129482 All targets in OG5_129482
Brugia malayi Protein kinase c protein 2 Get druggable targets OG5_129482 All targets in OG5_129482
Echinococcus granulosus protein kinase C gamma type Get druggable targets OG5_129482 All targets in OG5_129482
Candida albicans protein kinase C similar to S. cerevisiae PKC1 (YBL105C) Get druggable targets OG5_129482 All targets in OG5_129482
Loa Loa (eye worm) AGC/PKC/ALPHA protein kinase Get druggable targets OG5_129482 All targets in OG5_129482
Schistosoma japonicum ko:K06068 novel protein kinase C, putative Get druggable targets OG5_129314 All targets in OG5_129314
Schistosoma mansoni serine/threonine protein kinase Get druggable targets OG5_129314 All targets in OG5_129314
Echinococcus multilocularis serine:threonine protein kinase N2 Get druggable targets OG5_129314 All targets in OG5_129314
Echinococcus multilocularis RNA directed DNA polymerase Get druggable targets OG5_129482 All targets in OG5_129482
Schistosoma japonicum Protein kinase C alpha type, putative Get druggable targets OG5_129482 All targets in OG5_129482
Echinococcus granulosus RNA directed DNA polymerase Get druggable targets OG5_129482 All targets in OG5_129482
Echinococcus multilocularis telomerase reverse transcriptase subunit Get druggable targets OG5_129482 All targets in OG5_129482
Loa Loa (eye worm) AGC/PKC/ETA protein kinase Get druggable targets OG5_129314 All targets in OG5_129314
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_129482 All targets in OG5_129482

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis AGC family protein kinase 0.0067 0.0043 0.0074
Loa Loa (eye worm) transcription factor SMAD2 0.0121 0.1659 0.1623
Echinococcus granulosus arachidonate 5 lipoxygenase 0.012 0.1615 0.239
Echinococcus multilocularis Protein kinase C, brain isozyme 0.0216 0.4486 0.6756
Loa Loa (eye worm) AGC/PKC/ETA protein kinase 0.0287 0.662 0.6605
Trichomonas vaginalis glucosylceramidase, putative 0.0262 0.587 1
Loa Loa (eye worm) hypothetical protein 0.0143 0.2301 0.2267
Echinococcus multilocularis arachidonate 5 lipoxygenase 0.012 0.1615 0.239
Trichomonas vaginalis AGC family protein kinase 0.0067 0.0043 0.0074
Onchocerca volvulus 0.0333 0.7996 1
Toxoplasma gondii AGC kinase 0.0067 0.0043 0.5
Echinococcus multilocularis protein kinase c epsilon type 0.0287 0.662 1
Loa Loa (eye worm) hypothetical protein 0.0381 0.9413 0.941
Trichomonas vaginalis glucosylceramidase, putative 0.0172 0.3177 0.5412
Echinococcus granulosus Protein kinase C brain isozyme 0.0216 0.4486 0.6756
Trichomonas vaginalis AGC family protein kinase 0.0067 0.0043 0.0074
Trichomonas vaginalis glucosylceramidase, putative 0.0172 0.3177 0.5412
Loa Loa (eye worm) hypothetical protein 0.0333 0.7996 0.7987
Trichomonas vaginalis AGC family protein kinase 0.0067 0.0043 0.0074
Trichomonas vaginalis glucosylceramidase, putative 0.0172 0.3177 0.5412
Schistosoma mansoni serine/threonine protein kinase 0.0216 0.4486 0.6756
Echinococcus multilocularis RNA directed DNA polymerase 0.0095 0.0884 0.1278
Echinococcus granulosus protein kinase c epsilon type 0.0287 0.662 1
Loa Loa (eye worm) MH2 domain-containing protein 0.0121 0.1659 0.1623
Trichomonas vaginalis glucosylceramidase, putative 0.0262 0.587 1
Schistosoma mansoni lipoxygenase 0.012 0.1615 0.239
Loa Loa (eye worm) O-glycosyl hydrolase family 30 protein 0.0262 0.587 0.5852
Echinococcus multilocularis serine threonine protein kinase 0.0168 0.3069 0.4601
Trichomonas vaginalis glucosylceramidase, putative 0.0172 0.3177 0.5412
Trichomonas vaginalis glucosylceramidase, putative 0.0181 0.3454 0.5884
Trichomonas vaginalis AGC family protein kinase 0.0067 0.0043 0.0074
Echinococcus multilocularis serine:threonine protein kinase N2 0.0234 0.5022 0.757
Trypanosoma brucei rac serine-threonine kinase, putative 0.0067 0.0043 0.5
Brugia malayi protein kinase C II. 0.0287 0.662 1
Loa Loa (eye worm) hypothetical protein 0.0095 0.0884 0.0844
Echinococcus multilocularis protein kinase c iota type 0.0115 0.146 0.2155
Trichomonas vaginalis glucosylceramidase, putative 0.0262 0.587 1
Entamoeba histolytica PH domain containing protein kinase, putative 0.0168 0.306 1
Echinococcus granulosus protein kinase C gamma type 0.0168 0.3069 0.4601
Trichomonas vaginalis glucosylceramidase, putative 0.0262 0.587 1
Schistosoma mansoni atypical protein kinase C 0.0115 0.146 0.2155
Trichomonas vaginalis AGC family protein kinase 0.0067 0.0043 0.0074
Trichomonas vaginalis AGC family protein kinase 0.0067 0.0043 0.0074
Brugia malayi Protein kinase c protein 2 0.015 0.2525 0.3774
Trichomonas vaginalis glucosylceramidase, putative 0.0172 0.3177 0.5412
Schistosoma mansoni serine/threonine protein kinase 0.0216 0.4486 0.6756
Trichomonas vaginalis AGC family protein kinase 0.0067 0.0043 0.0074
Loa Loa (eye worm) hypothetical protein 0.0333 0.7996 0.7987
Trichomonas vaginalis glucosylceramidase, putative 0.0262 0.587 1
Schistosoma mansoni serine/threonine protein kinase 0.0287 0.662 1
Trichomonas vaginalis glucosylceramidase, putative 0.0172 0.3177 0.5412
Trichomonas vaginalis glucosylceramidase, putative 0.0262 0.587 1
Echinococcus granulosus RNA directed DNA polymerase 0.0095 0.0884 0.1278
Echinococcus granulosus serine:threonine protein kinase N2 0.0168 0.306 0.4588
Trichomonas vaginalis AGC family protein kinase 0.0067 0.0043 0.0074
Trichomonas vaginalis glucosylceramidase, putative 0.0181 0.3454 0.5884
Brugia malayi O-Glycosyl hydrolase family 30 protein 0.0262 0.587 0.886
Echinococcus multilocularis telomerase reverse transcriptase subunit 0.0095 0.0884 0.1278
Echinococcus granulosus protein kinase c iota type 0.0115 0.146 0.2155
Schistosoma mansoni lipoxygenase 0.0084 0.0539 0.0754
Trichomonas vaginalis AGC family protein kinase 0.0067 0.0043 0.0074
Brugia malayi MH2 domain containing protein 0.0121 0.1659 0.2457
Loa Loa (eye worm) AGC/PKC/ALPHA protein kinase 0.0103 0.1108 0.1069
Loa Loa (eye worm) hypothetical protein 0.0333 0.7996 0.7987
Trichomonas vaginalis glucosylceramidase, putative 0.0172 0.3177 0.5412
Trichomonas vaginalis AGC family protein kinase 0.0067 0.0043 0.0074

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) > 1000 nM Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay ChEMBL. 22078216
IC50 (binding) > 1000 nM Inhibition of recombinant human PKCbeta1 assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay ChEMBL. 22078216
IC50 (binding) > 1000 nM Inhibition of recombinant human PKCdelta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay ChEMBL. 22078216
IC50 (binding) > 1000 nM Inhibition of recombinant human PKCepsilon assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay ChEMBL. 22078216
IC50 (binding) > 1000 nM Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay ChEMBL. 22078216
IC50 (binding) > 1000 nM Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay ChEMBL. 22078216

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.